Keyword: Duke University School of Medicine
Datavant will partner its 150 data sets with the three organizations' unique capabilities to drive clinical trial intelligence.
Researchers at Duke University developing a glioblastoma treatment based on poliovirus are unraveling the process by which the virus fights malignancy.
Former FDA chief Califf leads a PCORI-backed research foundation, ex-Shire exec Shepard jumped to Eisai's oncology business, and Forty Seven hired former Sandoz exec McCamish as new CEO.
Using instant wave-free ratio (iFR), a pressure-derived index, could lead to quicker, more cost-effective heart disease diagnoses and treatments.
Scientists at Duke University Medical Center, the University of North Carolina, and the biotech MacroGenics have teamed up to design a molecule with the capacity to bind HIV-infected cells and unite them with the immune system's killer T cells.